Suboptimal adherence to food restrictions requirements related to drug regimens for chronic diseases.
Current Medical Research and Opinion 2023 March 14
BACKGROUND: Oral medications for chronic conditions often involve a variety of instructions, including time of day/dosing, drug interactions, and food intake restrictions. However, the extent to which patients are differentially aware of and able to follow these instructions is unclear.
METHODS: We surveyed patients from the US and Europe (UK, France, Germany, Italy, Spain) who were prescribed sulfonylureas (SU) for diabetes or levothyroxine for hypothyroidism. SUs included glimepiride (US/Europe), glipizide (US) or gliclazide (Europe). Patients rated their awareness of medication instructions at baseline and kept a daily diary for 3 to 5 days documenting their adherence to three aspects of their medication: dosing regimen including time of day, warning labels including drug interactions, and food restrictions.
RESULTS: A total of 421 US and 493 European patients took the study medications; 546 patients took SU and 368 took levothyroxine. Overall, 48% of patients were male; 46% were age 65 years or older. Despite most patients reporting having received instructions on medication requirements (US 71%, EU 75%), most patients reported being only somewhat knowledgeable (US 69%; EU 71%). Adherence, measured by the proportion of the days a participant was adherent to each category out of the observational period (ranging from 3-5 days), varied by type of instruction, with the poorest adherence observed for food restriction requirements (US 34% of the observation days, EU 26%) compared to warning labels (US 77%, EU 67%) and dosing regimen (US 85%, EU 87%).
CONCLUSIONS: Patients adhered to dosing and cautionary instructions across the majority of the study period but were largely non-adherent to food intake restrictions. One quarter of patients did not receive an in-person consultation regarding their medication requirements, and patient-reported medication knowledge was low across all participants. Improved communication and increased emphasis on food intake restrictions is needed when advising patients on their medications.
METHODS: We surveyed patients from the US and Europe (UK, France, Germany, Italy, Spain) who were prescribed sulfonylureas (SU) for diabetes or levothyroxine for hypothyroidism. SUs included glimepiride (US/Europe), glipizide (US) or gliclazide (Europe). Patients rated their awareness of medication instructions at baseline and kept a daily diary for 3 to 5 days documenting their adherence to three aspects of their medication: dosing regimen including time of day, warning labels including drug interactions, and food restrictions.
RESULTS: A total of 421 US and 493 European patients took the study medications; 546 patients took SU and 368 took levothyroxine. Overall, 48% of patients were male; 46% were age 65 years or older. Despite most patients reporting having received instructions on medication requirements (US 71%, EU 75%), most patients reported being only somewhat knowledgeable (US 69%; EU 71%). Adherence, measured by the proportion of the days a participant was adherent to each category out of the observational period (ranging from 3-5 days), varied by type of instruction, with the poorest adherence observed for food restriction requirements (US 34% of the observation days, EU 26%) compared to warning labels (US 77%, EU 67%) and dosing regimen (US 85%, EU 87%).
CONCLUSIONS: Patients adhered to dosing and cautionary instructions across the majority of the study period but were largely non-adherent to food intake restrictions. One quarter of patients did not receive an in-person consultation regarding their medication requirements, and patient-reported medication knowledge was low across all participants. Improved communication and increased emphasis on food intake restrictions is needed when advising patients on their medications.
Full text links
Trending Papers
The future of intensive care: the study of the microcirculation will help to guide our therapies.Critical Care : the Official Journal of the Critical Care Forum 2023 May 17
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app